Alexander J Thompson
Alexander J Thompson
Professor of Gastroenterology, St Vincent's Hospital, University of Melbourne
Geverifieerd e-mailadres voor svhm.org.au
Titel
Geciteerd door
Geciteerd door
Jaar
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
D Ge, J Fellay, AJ Thompson, JS Simon, KV Shianna, TJ Urban, ...
Nature 461 (7262), 399-401, 2009
40482009
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ...
Gastroenterology 139 (1), 120-129. e18, 2010
8952010
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The Lancet Gastroenterology & Hepatology 2 (3), 161-176, 2017
8742017
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
J Fellay, AJ Thompson, D Ge, CE Gumbs, TJ Urban, KV Shianna, LD Little, ...
Nature 464 (7287), 405-408, 2010
4902010
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
AJV Thompson, T Nguyen, D Iser, A Ayres, K Jackson, M Littlejohn, ...
Hepatology 51 (6), 1933-1944, 2010
4522010
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia
T Nguyen, AJV Thompson, S Bowden, C Croagh, S Bell, PV Desmond, ...
Journal of hepatology 52 (4), 508-513, 2010
4462010
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
JJ McCarthy, JH Li, A Thompson, S Suchindran, XQ Lao, K Patel, ...
Gastroenterology 138 (7), 2307-2314, 2010
4372010
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
4332014
IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C
TJ Urban, AJ Thompson, SS Bradrick, J Fellay, D Schuppan, KD Cronin, ...
Hepatology 52 (6), 1888-1896, 2010
4202010
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response
A Mangia, AJ Thompson, R Santoro, V Piazzolla, HL Tillmann, K Patel, ...
Gastroenterology 139 (3), 821-827. e1, 2010
3792010
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH ōvrehus, C Moreno, CE Brand„o Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
3092014
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY‐3+)
V Leroy, P Angus, JP Bronowicki, GJ Dore, C Hezode, S Pianko, S Pol, ...
Hepatology 63 (5), 1430-1441, 2016
2532016
Interleukin‐28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus†…
MR Charlton, A Thompson, BJ Veldt, K Watt, H Tillmann, JJ Poterucha, ...
Hepatology 53 (1), 317-324, 2011
2442011
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2262014
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction
AJ Thompson, J Fellay, K Patel, HL Tillmann, S Naggie, D Ge, TJ Urban, ...
Gastroenterology 139 (4), 1181-1189. e2, 2010
2022010
Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 phase 3 randomized trials
IM Jacobson, E Lawitz, EJ Gane, BE Willems, PJ Ruane, RG Nahass, ...
Gastroenterology 153 (1), 113-122, 2017
1952017
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis
AJ Muir, F Poordad, J Lalezari, G Everson, GJ Dore, R Herring, A Sheikh, ...
Jama 313 (17), 1736-1744, 2015
1382015
Interferon‐lambda genotype and low serum low‐density lipoprotein cholesterol levels in patients with chronic hepatitis C infection
JH Li, X Qian Lao, HL Tillmann, J Rowell, K Patel, A Thompson, ...
Hepatology 51 (6), 1904-1911, 2010
1292010
Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function
Y Hitomi, ET Cirulli, J Fellay, JG McHutchison, AJ Thompson, CE Gumbs, ...
Gastroenterology 140 (4), 1314-1321, 2011
1262011
Quantitation of pretreatment serum interferon‐γ–inducible protein‐10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment†…
JM Darling, J Aerssens, G Fanning, JG McHutchison, DB Goldstein, ...
Hepatology 53 (1), 14-22, 2011
1252011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20